ZEAL logo

ZEAL Zealand Pharma A/S

NASDAQ Global Select · Biotechnology · Healthcare

$17.59
+0.00 (+0.00%)

Zealand Pharma A/S is a Danish biotechnology firm dedicated to the identification, progression, and market introduction of peptide-based therapeutics. The company concentrates its efforts on treatments for gastrointestinal and metabolic ailments, as well as other specialized conditions where current medical options are insufficient. Its commercialized product, Dasiglucagon, is an injectable soluti…

Market Cap: $0.00www.zealandpharma.com

Price

No data yet.

Social Signal Score

48
5d
—
30d
—
60d
45
8 mentions
—
90d
52
17 mentions
—
news: 17

Analyst Ratings

5 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 1Sell 0Strong Sell 0
Avg price target$29+64.9%
Low $26Median $29High $32
Current Consensus

Revenue

$15.08M-87.47%
$0.00$73.67M$147.34M$221.02M
Mar 2012Mar 2022

Company Profile

CEO
Emmanuel Dulac PharmD, MBA
Sector
Healthcare
Industry
Biotechnology
Employees
237
Beta
1.34
Country
DK
www.zealandpharma.com